Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión) Open Journal Systems
PCR para COVID en el protocolo de trasplante / PCR for COVID in the transplant protocol
Resumen
Resumen
Introducción: desde que comenzó la pandemia por SARS-CoV-2, identificar la fisiopatología de la COVID-19 no solo se ha encaminado a aplicar pruebas diagnósticas o prevenir por medio de vacunas, sino también a la oportuna detección, sobre todo de pacientes de grupos de riesgo como los del área de trasplantes (renal, hematológico, etcétera). En el caso de estos pacientes, usar pruebas como la RT-PCR evita someterlos a estados de inmunosupresión que podrían agravar la situación en caso de que se encuentren ante un inicio de la infección por COVID-19.
Objetivo: exponer los resultados de las pruebas de SARS-CoV-2 aplicadas a pacientes de una unidad de trasplantes.
Material y métodos: estudio descriptivo, observacional, transversal y retrolectivo. Se recolectaron los datos de los resultados de las pruebas de RT-PCR para SARS-CoV-2 de pacientes sometidos a trasplante de junio de 2021 a abril de 2022 en un hospital de tercer nivel.
Resultados: se hicieron 755 pruebas a los pacientes sometidos a trasplante; 384 (50.8%) fueron mujeres. De todos los pacientes, solo 73 (9.7%) fueron positivos a SARS-CoV-2.
Conclusiones: implementar pruebas RT-PCR para detectar el SARS-CoV-2 como protocolo de trasplante previene complicaciones fatales derivadas de la infección por COVID a los donadores y a los receptores.
Abstract
Background: Since the beginning of the SARS-CoV-2 pandemic, identifying the COVID-19 pathophysiology not only has been addressed to applying diagnostic tests or preventing through vaccines, but also to the timely detection, especially of patients in risk groups such as those in transplants areas (renal, hematology, etcetera). In the case of these patients, using RT-PCR tests avoids putting them at risk by subjecting them to states of immunosuppression that could aggravate their situation if they were faced with an onset of a COVID-19 infection.
Objective: To present the results of patients of a transplant unit tested for SARS-CoV-2.
Material and methods: Descriptive, observational, cross-sectional, and retrolective study. Data of results of RT-PCR tests of patients who underwent transplantation from June 2021 to April 2022 in a third level hospital were collected.
Results: 755 tests were done to patients who underwent transplantation. 384 (50.8%) were women. Out of all patients, only 73 (9.7%) were positive to SARS-CoV-2.
Conclusions: Implementing RT-PCR tests as a transplant protocol to detect SARS-CoV-2 prevents fatal complications due to COVID infection to donors and receptors.
Palabras clave
Texto completo:
PDFReferencias
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. doi: 10.1038/s41586-020-2012-7.
Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J Clin Med. 2020;9(4):1225; doi: 10.3390/jcm9041225.
Sun J, He WT, Wang L, Lai A, Ji X, Zhai X et al. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med. 2020;26(5):483-95. doi: 10.1016/j.molmed.2020.02.008.
Placais L, Richier Q, Noel N, Lacombe K, Mariette X, Hermine O et al. Immune interventions in COVID-19: a matter of time? Mucosal Immunol. 2022;15(2):198-210. doi:10.1038/s41385-021-00464-w.
Li Q, Guan X, Pengwu, Wang X, Zhou L, Tong Y et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. 382(13):1199-207. doi: 10.1056/NEJMoa2001316.
Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27(1):28-33. doi: 10.1038/s41591-020-01202-8.
Lan FY, Filler R, Mathew S, Buley J, Iliaki E, Bruno-Murtha LA et al. COVID-19 symptoms predictive of healthcare workers’ SARSCoV-2 PCR results. PLoS ONE. 2020;15(6): e0235460. doi: 10.1371/journal.pone.0235460.
Guo J. Ge X, Guo Y. Recent advances in methods for the diagnosis of Corona Virus Disease 2019. J Clin Lab Anal. 2022;36(1):e24178 doi: 10.1002/jcla.24178.
Bastos ML, Tavaziva G, Abidi SK, Campbell JR, Haraoui LP, Johnston JC et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ. 2020;370:m2516 doi: 10.1136/bmj.m2516.
Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ et al. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 2020;6(5):591-605. doi: 10.1021/acscentsci.0c00501.
Zhou Y, Zhang L, Xie YH, Wu J. Advancements in detection of SARS-CoV-2 infection for confronting COVID-19 pandemics. Lab Invest. 2022;102(1):4-13. doi: 10.1038/s41374-021-00663-w.
Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020; 296(2):E32-40. doi: 10.1148/radiol.2020200642.
Younes N, Al-Sadeq DW, AL-Jighefee H, Younes S, Al-Jamal O, Daas HI et al. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses. 2020;12(6):582. doi: 10.3390/v12060582.
Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections–the state of the art. Emerg Microbes Infect. 2020;9(1:747-56. doi: 10.1080/22221751.2020.1745095.
Payne D, Newton D, Evans P, Osman H, Baretto R. Preanalytical issues affecting the diagnosis of COVID-19. J Clin Pathol. 2021;74(4):207-8. doi: 10.1136/jclinpath-2020-206751.
Arevalo-Rodriguez I, Buitrago-García D, Simancas-Racines D, Zambrano-Achig P, Del Campo R, Ciapponi A et al. False-negative results of initial RT-PCR assays for COVID-19: A systematic review. PLoS ONE. 2020;15(12):e0242958. doi: 10.1371/journal.pone.0242958.
Lázaro del Campo P, Ramírez-López A, de la Cruz-Benito B, de Paz-Arias R, de Soto-Álvarez T, Sánchez-Vadillo I et al. Hematopoietic cell transplantation during COVID-19 pandemic: experience from a tertiary hospital in Madrid. Expert Rev Hematol. 2021;14(1):1-5. doi: 10.1080/17474086.2021.1858789.
Worel N, Shaw BE, Aljurf M, Koh M, Seber A, Weisdorf D et al. Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation. Transplant Cell Ther. 2021;27(3):270.e1270.e6. doi: 10.1016/j.jtct.2020.11.019.
Elias M, Pievani D, Randoux C, Louis K, Denis B, Delion A et al. COVID-19 infection in kidney transplant recipients: disease incidence and clinical outcomes. J Am Soc Nephrol. 2020;31(10):2413-23. doi: 10.1681/ASN.2020050639.
Frick DN. A transplant recipient's pandemic perspective. Transpl Infect Dis. 2021;23(5):e13738. doi: 10.1111/tid.13738.
Sagnelli C, Sica A, Gallo M, Peluso G, Varlese F, D'Alessandro V et al. Renal involvement in COVID-19: focus on kidney transplant sector. Infection. 2021;49(6):1265-75. doi: 10.1007/s15010-021-01706-6.
Bossini N, Alberici F, Delbarba E, Valerio F, Manenti C, Possenti S et al. Kidney transplant patients with SARS-CoV-2 infection: the Brescia Renal COVID task force experience. Am J Transplant. 2020; 20(11):3019-29. doi: 10.1111/ajt.16176.
Nair V, Jandovitz N, Hirsch JS, Nair G, Abate M, Bhaskaran M, et al. COVID-19 in kidney transplant recipients. Am J Transplant. 2020; 20(7):1819–25. doi: 10.1111/ajt.15967.
Maurer K, Kim H, Kuczmarski T, Garrity HM, Weber A, Reynolds CG et al. Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and inmune reconstitution. Blood Adv. 2021;5(23):5140-9. doi: 10.1182/bloodadvances.2021005139.
Wiercinska E, Schlipfenbacher V, Bug G, Bader P, Verbeek M, Seifried E et al. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site. J Transl Med. 2021;19(1):145. doi: 10.1186/s12967-021-02810-9.
Enlaces refback
- No hay ningún enlace refback.